Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
September 30, 2021 2.76%
June 30, 2021 6.81%
March 31, 2021 -3.43%
December 31, 2020 -1.86%
September 30, 2020 -1.77%
June 30, 2020 -11.31%
March 31, 2020 4.32%
December 31, 2019 5.20%
September 30, 2019 2.56%
June 30, 2019 5.55%
March 31, 2019 3.83%
December 31, 2018 6.91%
September 30, 2018 6.59%
June 30, 2018 7.89%
March 31, 2018 7.42%
December 31, 2017 7.06%
September 30, 2017 5.92%
June 30, 2017 7.98%
March 31, 2017 7.08%
December 31, 2016 8.29%
September 30, 2016 9.66%
June 30, 2016 10.47%
March 31, 2016 9.80%
December 31, 2015 9.17%
September 30, 2015 10.56%
Date Value
June 30, 2015 11.11%
March 31, 2015 5.84%
December 31, 2014 4.87%
September 30, 2014 9.86%
June 30, 2014 10.99%
March 31, 2014 5.65%
December 31, 2013 7.60%
September 30, 2013 7.88%
June 30, 2013 7.65%
March 31, 2013 8.09%
December 31, 2012 10.39%
September 30, 2012 10.84%
June 30, 2012 11.97%
March 31, 2012 11.60%
December 31, 2011 12.28%
September 30, 2011 15.07%
June 30, 2011 15.46%
March 31, 2011 16.35%
December 31, 2010 15.35%
September 30, 2010 14.11%
June 30, 2010 14.00%
March 31, 2010 14.31%
December 31, 2009 13.84%
September 30, 2009 13.48%
June 30, 2009 14.84%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Regional Health Properties, Inc. 27.39%
Chemed Corp. 30.37%
The Ensign Group, Inc. 14.47%
National HealthCare Corp. 73.30%
Oncologix Tech, Inc. --